Galigniana Mario D, Harrell Jennifer M, O'Hagen Heather M, Ljungman Mats, Pratt William B
Departments of Pharmacology and Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
J Biol Chem. 2004 May 21;279(21):22483-9. doi: 10.1074/jbc.M402223200. Epub 2004 Mar 5.
The tumor suppressor protein p53 is known to be transported to the nucleus along microtubular tracks by cytoplasmic dynein. However, the connection between p53 and the dynein motor protein complex has not been established. Here, we show that hsp90.binding immunophilins link p53.hsp90 complexes to dynein and that prevention of that linkage in vivo inhibits the nuclear movement of p53. First, we show that p53.hsp90 heterocomplexes from DLD-1 human colon cancer cells contain an immunophilin (FKBP52, CyP-40, or PP5) as well as dynein. p53.hsp90.immunophilin.dynein complexes can be formed by incubating immunopurified p53 with rabbit reticulocyte lysate, and we show by peptide competition that the immunophilins link via their tetratricopeptide repeat domains to p53-bound hsp90 and by means of their PPIase domains to the dynein complex. The linkage of immunophilins to the dynein motor is indirect by means of the dynamitin component of the dynein-associated dynactin complex, and we show that purified FKBP52 binds directly by means of its PPIase domain to purified dynamitin. By using a temperature-sensitive mutant of p53 where cytoplasmic-nuclear movement occurs by shift to permissive temperature, we show that p53 movement is impeded when p53 binding to hsp90 is inhibited by the hsp90 inhibitor radicicol. Also, nuclear movement of p53 is inhibited when immunophilin binding to dynein is competed for by expression of a PPIase domain fragment in the same manner as when dynein linkage to cargo is dissociated by expression of dynamitin. This is the first demonstration of the linkage between an hsp90-chaperoned transcription factor and the system for its retrograde movement to the nucleus both in vitro and in vivo.
肿瘤抑制蛋白p53已知通过胞质动力蛋白沿微管轨道转运至细胞核。然而,p53与动力蛋白运动蛋白复合体之间的联系尚未确立。在此,我们表明热休克蛋白90(hsp90)结合亲免素将p53-hsp90复合体与动力蛋白相连,且在体内阻断这种联系会抑制p53的核转运。首先,我们发现来自DLD-1人结肠癌细胞的p53-hsp90异源复合体包含一种亲免素(FKBP52、CyP-40或PP5)以及动力蛋白。通过将免疫纯化的p53与兔网织红细胞裂解物孵育,可形成p53-hsp90-亲免素-动力蛋白复合体,并且我们通过肽竞争实验表明,亲免素通过其四肽重复结构域与结合p53的hsp90相连,并通过其肽脯氨酰顺反异构酶(PPIase)结构域与动力蛋白复合体相连。亲免素与动力蛋白马达的联系是通过动力蛋白相关的动力蛋白激活蛋白复合体的动力素成分间接实现的,并且我们表明纯化的FKBP52通过其PPIase结构域直接与纯化的动力素结合。利用p53的温度敏感突变体,在转移至允许温度时会发生胞质-核转运,我们发现当hsp90抑制剂雷帕霉素抑制p53与hsp90的结合时,p53的转运受到阻碍。同样,当通过表达PPIase结构域片段竞争亲免素与动力蛋白的结合时,p53的核转运受到抑制,其方式与通过表达动力素解离动力蛋白与货物的联系时相同。这是首次在体外和体内证明hsp90伴侣化转录因子与其向细胞核逆行转运系统之间的联系。